FDA panel will hold public hearing on orphan drug research

06/28/2010 | Reuters

A new FDA committee will hold a two-day public hearing this week to discuss new strategies that would encourage drugmakers to develop treatments for rare diseases. BIO has been lobbying for increased incentives for orphan drug research as well as longer market protection for orphan products in the U.S.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC